- Going concern
- Material uncertainty
- Principal risks
- 12
| 1 Jan 2025 | Annual Report and Accounts 2023-2024 | |
| 29 Mar 2024 | Annual Report and Accounts (to 2023-09-30) | |
| 22 Mar 2023 | Annual Report and Accounts (to 2022-09-30) |
Redx Pharma is a biotech company in the clinical stage that specializes in finding and creating new, precise, small molecule treatments for cancer and fibrosis.
| 1 Jan 2025 | Annual Report and Accounts 2023-2024 | |
| 29 Mar 2024 | Annual Report and Accounts (to 2023-09-30) | |
| 22 Mar 2023 | Annual Report and Accounts (to 2022-09-30) |
Redx Pharma is a biotech company in the clinical stage that specializes in finding and creating new, precise, small molecule treatments for cancer and fibrosis.
